This is the authors' abstract. We don't add key points for this paper.
Although group B streptococci are highly susceptible to penicillin and other antimicrobial agents the mortality in early onset disease approaches 50%. Very little is known about the precise pathophysiology of group B streptococcal sepsis and its attendant hematologic, hemodynamic, and immunologic abnormalities. The cause of death in babies is usually shock that is unresponsive to conventional restoration of vascular volume and pharmacologic pressor agents. The findings reported by Short and colleagues in this issue of Pediatrics1 utilizing the suckling rat model of group B streptococcal sepsis are notable. However, caution is necessary in analyzing the results. A strong plea must be made to discourage haphazard human trials with nonsteroidal anti-inflammatory drugs prior to additional confirmatory studies in the rat group B streptococcal sepsis model, and the performance of similar experiments in larger animal model systems.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cherry et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: